Toggle Main Menu Toggle Search

Open Access padlockePrints

The investigation and management of metabolic myopathies

Lookup NU author(s): Professor Robert Taylor


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Metabolic myopathies (MM) are rare inherited primary muscle disorders that are mainly due to abnormalities of muscle energy metabolism resulting in skeletal muscle dysfunction. These diseases include disorders of fatty acid oxidation, glyco(geno)lytic muscle disorders and mitochondrial respiratory chain (MRC) disease. Clinically these disorders present with a range of symptoms including infantile hypotonia, myalgia/exercise tolerance, chronic or acute muscle weakness, cramps/spasms/stiffness or episodic acute rhabdomyolysis. The precipitant may be fasting, infection, general anaesthesia, heat/cold or most commonly, exercise. However, the differential diagnosis includes a wide range of both acquired and inherited conditions and these include exposure to drugs/toxins, inflammatory myopathies, dystrophies and channelopathies. Streamlining of existing diagnostic protocols has now become a realistic prospect given the availability of second-generation sequencing. A diagnostic pathway using a 'rhabdomyolysis' gene panel at an early stage of the diagnostic process is proposed. Following detailed clinical evaluation and first-line investigations, some patients will be identified as candidates for McArdle disease/glycogen storage disease type V or MRC disease and these will be referred directly to the specialised services. However, for the majority of patients, second-line investigation is best undertaken through next-generation sequencing using a 'rhabdomyolysis' gene panel. Following molecular analysis and careful evaluation of the findings, some patients will receive a clear diagnosis. Further functional or specific targeted testing may be required in other patients to evaluate the significance of uncertain/equivocal findings. For patients with no clear diagnosis, further investigations will be required through a specialist centre.

Publication metadata

Author(s): Olpin SE, Murphy E, Kirk RJ, Taylor RW, Quinlivan R

Publication type: Article

Publication status: Published

Journal: Journal of Clinical Pathology

Year: 2015

Volume: 68

Issue: 6

Pages: 410-417

Print publication date: 01/06/2015

Online publication date: 15/04/2015

Acceptance date: 25/03/2015

ISSN (print): 0021-9746

ISSN (electronic): 1472-4146

Publisher: BMJ Group


DOI: 10.1136/jclinpath-2014-202808


Altmetrics provided by Altmetric


Funder referenceFunder name
096919Wellcome Trust
MR/K000608/1Medical Research Council